Is MORN a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Morningstar (MORN) rests on PitchBook and private-markets data: PitchBook is Morningstar's marquee growth asset, supplying data, analytics, and AI-enabled software across venture capital, private equity, private credit, and M&A. Revenue (TTM) is ~$2.5B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Credit-ratings revenue is cyclical and tracks debt-issuance volumes, so a slowdown in structured finance or corporate issuance can quickly pressure a fast-growing segment. Whether MORN is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Morningstar is an investment-research and financial-data provider whose products span five reportable segments: the Morningstar Direct Platform (data, research, Direct, and Advisor Workstation), PitchBook (private-capital data, analytics, and AI-enabled software for venture capital, private equity, private credit, and M&A), Morningstar Credit (credit ratings, research, and analytics through DBRS Morningstar), Morningstar Wealth (investment products, advisor platforms, and managed portfolios), and Morningstar Retirement. The business is built on proprietary datasets, independent research, and widely used ratings and indexes that embed deeply into advisor, asset-manager, and institutional workflows, giving it high switching costs and durable, largely recurring revenue. The investment picture centers on a shift in growth mix away from the mature core fund-research business toward faster-growing franchises. PitchBook continues to expand private-market data and AI features, Morningstar Credit has rebounded strongly with structured-finance and corporate ratings activity, and management has focused on margin discipline after a heavy investment period, which drove sharp operating-leverage gains in recent quarters. The tradeoff is that revenue growth is roughly low-double-digit rather than explosive, parts of the business are cyclical (ratings volumes track debt issuance, and license revenue tracks markets), and the stock reprices with both software and financial-data sentiment. At a mid-teens to high-teens earnings multiple, the shares price in steady growth plus continued margin recovery rather than a dramatic re-acceleration.
What's the case for buying MORN?
1. PitchBook and private-markets data
PitchBook is Morningstar's marquee growth asset, supplying data, analytics, and AI-enabled software across venture capital, private equity, private credit, and M&A. As allocators push further into private markets and demand better data, PitchBook keeps adding users and expanding internationally, layering AI features onto a deep proprietary dataset.
2. Morningstar Credit (DBRS) rebound
The credit segment posted roughly 38% revenue growth in Q1 2026, led by structured finance and broader ratings activity. Credit is the most cyclical piece, tied to debt-issuance volumes, but a recovery in issuance and share gains in specific asset classes make it a swing factor for consolidated growth.
3. Margin expansion and operating leverage
After a period of heavy investment, Morningstar has prioritized cost discipline, which drove operating profit up more than 35% and diluted EPS up roughly 50% year over year in Q1 2026 on about 11% revenue growth. Continued leverage on a largely fixed data-and-research cost base is central to the earnings story.
4. Recurring subscriptions and data moat
Much of Morningstar's revenue is recurring license and subscription income across Direct, Data, and Advisor Workstation, embedded in advisor and institutional workflows. Its widely cited ratings, indexes, and datasets create high switching costs and a durable base to cross-sell newer AI and analytics products into.
What are the risks to MORN?
Credit-ratings revenue is cyclical and tracks debt-issuance volumes, so a slowdown in structured finance or corporate issuance can quickly pressure a fast-growing segment. Core fund-research and license revenue is more mature and exposed to market levels and fee compression among asset-manager clients. Morningstar competes against far larger, better-capitalized data and index rivals (Bloomberg, S&P Global, MSCI, FactSet, LSEG, Moody's) that can bundle products and pressure pricing. AI and new fintech entrants could commoditize parts of the data and research business over time. The stock trades at a premium multiple, so any stall in PitchBook growth, credit volumes, or margin recovery can compress the valuation.
How is MORN valued? (as of July 2026)
Snapshot for MORN as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$2.5B
- Q1 2026 revenue: ~$644.8M (up ~10.8% YoY)
- Q1 2026 diluted EPS: ~$2.73 (up ~50% YoY)
- Morningstar Credit growth: ~+38% YoY (Q1 2026)
- Market cap: ~$7B
- P/E (TTM): ~18x
Morningstar reported Q1 2026 revenue near $644.8 million, up about 11% year over year, with operating profit up more than 35% and diluted EPS around $2.73, up roughly 50%, both ahead of consensus. Growth was broad-based but led by Morningstar Credit (up about 38%) and PitchBook, and the company continued buying back stock. At a mid-to-high-teens trailing earnings multiple, the shares reflect steady growth plus continued margin recovery rather than a sharp re-acceleration.
How do you decide if MORN is a buy?
Rather than asking whether MORN is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold MORN indirectly through an index or sector ETF before adding more.
For the full picture, see the MORN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about MORN against your real portfolio and see your actual exposure before deciding.
The bottom line on MORN
The bottom line: Morningstar's story right now is PitchBook and private-markets data, with revenue (ttm) at ~$2.5B. If you believe that narrative continues, the call is about sizing MORN sensibly and checking overlap with what you own; if you doubt it (the risk: credit-ratings revenue is cyclical and tracks debt-issuance volumes, so a slowdown in structured finance or corporate issuance can quickly pressure a fast-growing segment.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around MORN with Walnut
Use Morningstar as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is MORN a good stock to buy right now?
+
The case for Morningstar right now is PitchBook and private-markets data, with revenue (ttm) at ~$2.5B. If you believe that thesis holds, MORN is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is credit-ratings revenue is cyclical and tracks debt-issuance volumes, so a slowdown in structured finance or corporate issuance can quickly pressure a fast-growing segment. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Morningstar do?
+
Morningstar is an investment-research and financial-data provider whose products span five reportable segments: the Morningstar Direct Platform (data, research, Direct, and Advisor
What are the main risks of MORN?
+
Credit-ratings revenue is cyclical and tracks debt-issuance volumes, so a slowdown in structured finance or corporate issuance can quickly pressure a fast-growing segment. Core fund-research and license revenue is more mature and exposed to market levels and fee compression among asset-manager clients. Morningstar competes against far larger, better-capitalized data and index rivals (Bloomberg, S&P Global, MSCI, FactSet, LSEG, Moody's) that can bundle products and pressure pricing. AI and new fintech entrants could commoditize parts of the data and research business over time. The stock trades at a premium multiple, so any stall in PitchBook growth, credit volumes, or margin recovery can compress the valuation.
What does Morningstar do?
+
Morningstar is a financial-data and independent-research company. It sells investment data, research, ratings, indexes, and software to advisors, asset managers, and institutions across five segments: the Direct Platform, PitchBook, Morningstar Credit, Wealth, and Retirement.
What are Morningstar's business segments?
+
Its reportable segments are Morningstar Direct Platform (data and research tools), PitchBook (private-market data and analytics), Morningstar Credit (DBRS ratings and credit analytics), Morningstar Wealth (advisor platforms and managed portfolios), and Morningstar Retirement (retirement-plan products).
Is Morningstar profitable?
+
Yes. Morningstar is consistently profitable and generates significant free cash flow. In Q1 2026 it reported operating profit up more than 35% and diluted EPS around $2.73, up roughly 50% year over year, driven by revenue growth and margin expansion.
What is driving Morningstar's growth?
+
Recent growth has been led by PitchBook in private-market data and by Morningstar Credit, which grew about 38% in Q1 2026 on stronger ratings activity. Margin discipline after a heavy investment period has also boosted earnings faster than revenue.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell MORN; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.